Giacomini P, Veglia F, Cordiali Fei P, Rehle T, Natali P G, Ferrone S
Cancer Res. 1984 Mar;44(3):1281-7.
Utilizing double-determinant immunoassays (DDIAs), the high-molecular-weight melanoma-associated antigen (HMW-MAA) was detected only in fetal skin and in one nipple of 54 normal tissues from adults tested, while the cytoplasmic MAA recognized by the monoclonal antibody 465. 12S was found in most of the normal tissues tested. Among malignant lesions, the HMW-MAA was found in melanomas, astrocytomas, and skin carcinomas; the cytoplasmic MAA was found in all of the malignant lesions tested, even those which originated from normal tissues without detectable cytoplasmic MAA. The levels of the HMW-MAA and of the cytoplasmic MAA showed marked variations in malignant lesions removed from various patients, as well as in autologous metastatic lesions removed from four patients with melanoma. No relationship was found between the degree of expression of the two MAA analyzed and the clinical stage of the disease. Both types of MAA were found in sera from patients with melanoma or other types of cancers, as well as in sera from healthy donors. The level of the HMW-MAA tended to be higher in patients with Stage IV melanoma.
利用双决定簇免疫测定法(DDIAs),仅在胎儿皮肤以及所检测的54份成人正常组织样本中的一个乳头中检测到高分子量黑色素瘤相关抗原(HMW-MAA),而单克隆抗体465.12S识别的细胞质MAA在大多数所检测的正常组织中均有发现。在恶性病变中,HMW-MAA见于黑色素瘤、星形细胞瘤和皮肤癌;细胞质MAA在所有所检测的恶性病变中均有发现,甚至包括那些起源于未检测到细胞质MAA的正常组织的病变。HMW-MAA和细胞质MAA的水平在不同患者切除的恶性病变以及从4例黑色素瘤患者切除的自体转移病变中均表现出显著差异。所分析的两种MAA的表达程度与疾病的临床分期之间未发现相关性。两种类型的MAA均在黑色素瘤或其他类型癌症患者的血清中以及健康供者的血清中被发现。IV期黑色素瘤患者中HMW-MAA的水平往往较高。